Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Food and Drug Administration (FDA)
Biotech
Former FDA official Peter Marks joins Eli Lilly
Six months after his departure from the federal government, Peter Marks, M.D., Ph.D., has joined Eli Lilly.
Darren Incorvaia
,
Eric Sagonowsky
Oct 7, 2025 3:49pm
Rocket aborts mission to get rare disease gene therapy approved
Oct 3, 2025 9:30am
IO lays off 50% after FDA derails cancer vaccine approval plan
Sep 29, 2025 8:55am
Takeda taps longtime Lilly exec as US head—Chutes & Ladders
Sep 12, 2025 8:30am
Trump admin mulls 'severe restrictions' on new China drugs: NYT
Sep 10, 2025 9:16am
Capricor responds to cell therapy snub, disputes FDA’s concerns
Sep 9, 2025 11:44am